H. Pakkenberg

4.6k total citations
108 papers, 3.4k citations indexed

About

H. Pakkenberg is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, H. Pakkenberg has authored 108 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Neurology, 27 papers in Cellular and Molecular Neuroscience and 19 papers in Molecular Biology. Recurrent topics in H. Pakkenberg's work include Neurological disorders and treatments (27 papers), Parkinson's Disease Mechanisms and Treatments (25 papers) and Neuroscience and Neuropharmacology Research (18 papers). H. Pakkenberg is often cited by papers focused on Neurological disorders and treatments (27 papers), Parkinson's Disease Mechanisms and Treatments (25 papers) and Neuroscience and Neuropharmacology Research (18 papers). H. Pakkenberg collaborates with scholars based in Denmark, United States and Norway. H. Pakkenberg's co-authors include Bente Pakkenberg, R. Fog, A. Randrup, Amy K. Stark, Arne Møller, H.J.G. Gundersen, Agnete Mouritzen Dam, Lisbeth Regeur, Rasmus Fog and Richard S. Burns and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Neurology.

In The Last Decade

H. Pakkenberg

102 papers receiving 3.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Pakkenberg Denmark 30 1.3k 1.1k 680 545 498 108 3.4k
I J Kopin United States 34 2.1k 1.7× 793 0.7× 1.1k 1.6× 667 1.2× 285 0.6× 70 4.2k
Hirotaro Narabayashi Japan 33 1.9k 1.4× 2.8k 2.5× 837 1.2× 473 0.9× 1.1k 2.2× 143 4.5k
Anders Nobin Sweden 33 2.3k 1.8× 755 0.7× 1.1k 1.7× 655 1.2× 163 0.3× 94 4.5k
George J. Siegel United States 24 1.2k 0.9× 350 0.3× 1.3k 1.9× 643 1.2× 297 0.6× 53 3.1k
William Bondareff United States 34 1.4k 1.1× 382 0.3× 975 1.4× 1.2k 2.1× 722 1.4× 87 3.6k
Robert C. Collins United States 28 2.3k 1.8× 453 0.4× 1.2k 1.8× 327 0.6× 249 0.5× 49 3.4k
U. K. Rinne Finland 46 2.0k 1.5× 3.6k 3.2× 905 1.3× 756 1.4× 617 1.2× 228 6.2k
F Seitelberger Austria 25 2.3k 1.8× 2.2k 1.9× 1.7k 2.6× 1.3k 2.4× 958 1.9× 131 5.5k
Peter S. Whitton United Kingdom 31 2.2k 1.7× 921 0.8× 1.1k 1.7× 654 1.2× 425 0.9× 78 3.9k
A. Wauquier Belgium 36 1.7k 1.3× 369 0.3× 800 1.2× 474 0.9× 354 0.7× 131 3.9k

Countries citing papers authored by H. Pakkenberg

Since Specialization
Citations

This map shows the geographic impact of H. Pakkenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Pakkenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Pakkenberg more than expected).

Fields of papers citing papers by H. Pakkenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Pakkenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Pakkenberg. The network helps show where H. Pakkenberg may publish in the future.

Co-authorship network of co-authors of H. Pakkenberg

This figure shows the co-authorship network connecting the top 25 collaborators of H. Pakkenberg. A scholar is included among the top collaborators of H. Pakkenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Pakkenberg. H. Pakkenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dupont, E., Anne‐Marie Nybo Andersen, J. Boas, et al.. (2009). Sustained-release Madopar HBS® compared with standard Madopar® in the long-term treatment of de novo parkinsonian patients. Acta Neurologica Scandinavica. 93(1). 14–20. 32 indexed citations
3.
Fabricius, Katrine, H. Pakkenberg, & Bente Pakkenberg. (2007). No changes in neocortical cell volumes or glial cell numbers in chronic alcoholic subjects compared to control subjects. Alcohol and Alcoholism. 42(5). 400–406. 20 indexed citations
4.
Stark, Amy K., Mette Toft, H. Pakkenberg, et al.. (2007). The effect of age and gender on the volume and size distribution of neocortical neurons. Neuroscience. 150(1). 121–130. 27 indexed citations
5.
Wermuth, Lene, H. Pakkenberg, & Bernard Jeune. (2004). High age-adjusted prevalence of Parkinson’s disease among Inuit in Greenland. International Journal of Circumpolar Health. 63(sup2). 369–370. 10 indexed citations
6.
Wermuth, Lene, et al.. (2004). Clinical characteristics of Parkinson's disease among Inuit in Greenland and inhabitants of the Faroe Islands and Als (Denmark). Movement Disorders. 19(7). 821–824. 6 indexed citations
7.
Bak, Mads, Claus Hansen, Karen Friis Henriksen, et al.. (2004). Mutation analysis of the Sonic hedgehog promoter and putative enhancer elements in Parkinson's disease patients. Molecular Brain Research. 126(2). 207–211. 4 indexed citations
8.
Marner, Lisbeth, et al.. (2004). No global loss of neocortical neurons in parkinson's disease: A quantitative stereological study. Movement Disorders. 20(2). 164–171. 41 indexed citations
9.
Pakkenberg, H., et al.. (2003). Neocortical Glial Cell Numbers in Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders. 16(4). 212–219. 65 indexed citations
10.
Thune, Jens Jakob, et al.. (2002). Ageing of substantia nigra in humans: 
cell loss may be compensated by hypertrophy. Neuropathology and Applied Neurobiology. 28(4). 283–291. 109 indexed citations
11.
Gredal, Ole, H. Pakkenberg, Merete Karlsborg, & Bente Pakkenberg. (2000). Unchanged total number of neurons in motor cortex and neocortex in amyotrophic lateral sclerosis: a stereological study. Journal of Neuroscience Methods. 95(2). 171–176. 46 indexed citations
12.
Pakkenberg, H., Birgitte Andersen, Richard S. Burns, & Bente Pakkenberg. (1995). A stereological study of substantia nigra in young and old rhesus monkeys. Brain Research. 693(1-2). 201–206. 32 indexed citations
13.
Pakkenberg, H.. (1993). Uridine uptake pattern in the cerebral cortex of grivet monkey. Neurochemistry International. 22(4). 385–393. 1 indexed citations
14.
Pakkenberg, Bente, Arne Møller, H.J.G. Gundersen, Agnete Mouritzen Dam, & H. Pakkenberg. (1991). The absolute number of nerve cells in substantia nigra in normal subjects and in patients with Parkinson's disease estimated with an unbiased stereological method.. Journal of Neurology Neurosurgery & Psychiatry. 54(1). 30–33. 330 indexed citations
15.
Povlsen, Uffe Juul & H. Pakkenberg. (1990). Effect of intravenous injection of biperiden and clonazepam in dystonia. Movement Disorders. 5(1). 27–31. 5 indexed citations
16.
Güttler, F., et al.. (1989). Tetrahydrobiopterin and Parkinson's disease. Acta Neurologica Scandinavica. 79(6). 493–499. 8 indexed citations
17.
Burns, Richard S., Peter A. LeWitt, Michael H. Ebert, H. Pakkenberg, & Irwin J. Kopin. (1985). The Clinical Syndrome of Striatal Dopamine Deficiency. New England Journal of Medicine. 312(22). 1418–1421. 172 indexed citations
18.
Pakkenberg, H. & R. Fog. (1983). Uridine uptake by nerve cells of the grivet monkey and its relation to cytoplasmic ribonucleic acid concentration. Neurochemistry International. 5(5). 553–557. 3 indexed citations
19.
Pakkenberg, H., et al.. (1982). Effect of CO2 on labelling of nerve and liver cells by nucleic acid precursors. Neurochemistry International. 4(1). 23–25. 1 indexed citations
20.
Fog, R. & H. Pakkenberg. (1976). Relative uptake of tritiated uridine in various brain areas in the mouse. Journal of Neurochemistry. 27(5). 1261–1262. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by I J Kopin Breakdown of academic impact, for papers by Hirotaro Narabayashi Breakdown of academic impact, for papers by Anders Nobin Breakdown of academic impact, for papers by George J. Siegel Breakdown of academic impact, for papers by William Bondareff Breakdown of academic impact, for papers by Robert C. Collins Breakdown of academic impact, for papers by U. K. Rinne Breakdown of academic impact, for papers by F Seitelberger Breakdown of academic impact, for papers by Peter S. Whitton Breakdown of academic impact, for papers by A. Wauquier
Rankless by CCL
2026